EndoShunt Medical
EndoShunt is dedicated to ending preventable abdominal hemorrhage death and improving patient outcomes by providing trauma surgeons with innovative, minimally invasive, and targeted hemorrhage control solutions. Their mission is to give trauma surgeons the gift of time so they can save lives, with a vision to revolutionize hemorrhage treatment and patient care.
Industries
Nr. of Employees
small (1-50)
EndoShunt Medical
965 West Chicago Ave, Chicago, IL 60642
Products
Temporary length-adjustable endovascular shunt (prototype device)
A temporary intravascular shunt system designed for rapid, blind or guidewire-free placement in major abdominal vessels to control hemorrhage while maintaining distal flow; incorporates adjustable occlusion zone, atraumatic tip, ergonomic handle, and length markings.
Temporary length-adjustable endovascular shunt (prototype device)
A temporary intravascular shunt system designed for rapid, blind or guidewire-free placement in major abdominal vessels to control hemorrhage while maintaining distal flow; incorporates adjustable occlusion zone, atraumatic tip, ergonomic handle, and length markings.
Services
Support for targeted pilot launches at select hospitals to collect usage, training, and outcome data to inform wider commercialization.
Support for targeted pilot launches at select hospitals to collect usage, training, and outcome data to inform wider commercialization.
Expertise Areas
- Endovascular device development
- Trauma device clinical validation
- Pre-clinical testing and animal models
- Regulatory strategy for 510(k) submissions
Key Technologies
- Endovascular catheter delivery systems
- Temporary intravascular occlusion devices
- Guidewire-free catheter deployment
- Porcine acute injury preclinical models
News & Updates
The NSF I-Corps Grant is a prestigious customer discovery grant in the US for research-based start-ups, including an eight-week bootcamp and a $50,000 grant for customer discovery and validation.
EndoShunt is seeking trauma and critical care community members for interviews as part of their NSF I-Corps customer discovery process.
Seisa Medical and its subsidiary Burpee Medsystems will begin designing and manufacturing EndoShunt’s first set of devices, combining high-quality manufacturing capabilities with EndoShunt’s innovative technology.
EndoShunt was listed as selectable for the Air Force’s open topic SBIR grant Afwerx, aiming to empower trauma surgeons with advanced hemorrhage control tools.
EndoShunt participated in the Eastern Association for the Surgery of Trauma annual assembly to introduce its technology to the trauma community and seek research partnerships.
Data from aortic simulator tests shows EndoShunt’s ability to control hemorrhage rapidly, in under 30 seconds.
The NSF I-Corps Grant is a prestigious customer discovery grant in the US for research-based start-ups, including an eight-week bootcamp and a $50,000 grant for customer discovery and validation.
EndoShunt is seeking trauma and critical care community members for interviews as part of their NSF I-Corps customer discovery process.
Seisa Medical and its subsidiary Burpee Medsystems will begin designing and manufacturing EndoShunt’s first set of devices, combining high-quality manufacturing capabilities with EndoShunt’s innovative technology.
EndoShunt was listed as selectable for the Air Force’s open topic SBIR grant Afwerx, aiming to empower trauma surgeons with advanced hemorrhage control tools.
EndoShunt participated in the Eastern Association for the Surgery of Trauma annual assembly to introduce its technology to the trauma community and seek research partnerships.
Data from aortic simulator tests shows EndoShunt’s ability to control hemorrhage rapidly, in under 30 seconds.